News | January 15, 2024
Lupin Life hosted Second Edition of Aptivate Champion Run for Kids
The Aptivate Champion Run witnessed an enthusiastic participation of over 4,000 Mumbaikars
The Aptivate Champion Run witnessed an enthusiastic participation of over 4,000 Mumbaikars
India’s First Integrated Ayush Wellness Centre to come up in Guwahati, foundation stone laid
The workshop was conducted as a part of the NITI–State workshop series
He is also inducted as a member of the management council and senior management personnel of the company
Signs MoU with the Govt. of Gujarat at Vibrant Gujarat Summit
Launch innovative vitamin sublingual sprays
Acquisition expands GSK’s respiratory pipeline adding AIO-001, a phase II-ready, long-acting antibody targeting the clinically validated TSLP pathway
TALZENNA is the first and only PARP inhibitor approved in combination with standard of care XTANDI for mCRPC patients in the European Union
This investment will be made by Caplin Point Laboratories Limited and its subsidiaries - Caplin Steriles Limited and Caplin One Labs Limited
The primary goal of this joint venture is to develop and commercialise novel cell therapy products for major unmet medical needs in the United States, Japan, and EU regions
Subscribe To Our Newsletter & Stay Updated
